Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MYC | P01106 | 1/20 | 0.40 |
| ▸ | MALT1 | Q9UDY8 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | DHODH | Q02127 | 2/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29437214 | 1.00 | LMNA (0.40) | LMNAMYCMALT1MEN1KMT2A | |
| SCHEMBL29437215 | 0.85 | PDE4B (0.54) | LMNAKDM4EGAAHSD11B1PDE4B | |
| SCHEMBL22558023 | 0.85 | PDE4B (0.54) | LMNAKDM4EGAAHSD11B1PDE4B | |
| SCHEMBL29437212 | 0.85 | PDE4B (0.54) | LMNAKDM4EGAAHSD11B1PDE4B | |
| SCHEMBL21822480 | 0.78 | MALT1 (0.38) | LMNAMYCMALT1MEN1KMT2A | |
| SCHEMBL27912745 | 0.78 | MALT1 (0.38) | LMNAMYCMALT1DHODHSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL28899877 | 0.77 | MALT1 (0.38) | LMNAMYCMALT1DHODHSMN1; SMN2 | |
| SCHEMBL29232359 | 0.76 | MALT1 (0.35) | LMNAMYCMALT1MEN1KMT2A | |
| SCHEMBL15122139 | 0.76 | SLC22A12 (0.38) | MYCMALT1 | |
| SCHEMBL28824119 | 0.75 | KDM4E (0.36) | LMNAMYCMALT1KDM4EDHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12459913-B2 | Preparation of substituted pyrazoles and their use as anthranilamides precursors | ADAMA MAKHTESHIM LTD. (IL) | 2025-11-04 | — | — | US | disclosed |
| US-20220177444-A1 | PREPARATION OF SUBSTITUTED PYRAZOLES AND THEIR USE AS ANTHRANILAMIDES PRECURSORS | ADAMA MAKHTESHIM LTD. (IL) | 2022-06-09 | — | — | US | disclosed |
| US-20220177444-A1 | PREPARATION OF SUBSTITUTED PYRAZOLES AND THEIR USE AS ANTHRANILAMIDES PRECURSORS | ADAMA MAKHTESHIM LTD. (IL) | 2022-06-09 | — | — | US | disclosed |
| EP-3956314-A1 | PREPARATION OF SUBSTITUTED PYRAZOLES AND THEIR USE AS ANTHRANILAMIDES PRECURSORS | Adama Makhteshim Ltd. (IL) | 2022-02-23 | — | — | EP | disclosed |
| CN-113874356-A | Preparation of substituted pyrazoles and their use as anthranilamide precursors | 安道麦马克西姆有限公司 | 2021-12-31 | — | — | CN | disclosed |
| CN-111825653-A | Preparation of substituted pyrazoles and use thereof as anthranilamide precursors | 安道麦马克西姆有限公司 | 2020-10-27 | — | — | CN | disclosed |
| WO-2020212991-A1 | PREPARATION OF SUBSTITUTED PYRAZOLES AND THEIR USE AS ANTHRANILAMIDES PRECURSORS | ADAMA MAKHTESHIM LTD. (IL) | 2020-10-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220177444-A1 | PREPARATION OF SUBSTITUTED PYRAZOLES AND THEIR USE AS ANTHRANILAMIDES PRECURSORS | CYP2F1, PPOX, CYP11B2 | LMNA 2820/4885MYC 3659/4885MALT1 2465/4885 |
| US-12459913-B2 | Preparation of substituted pyrazoles and their use as anthranilamides precursors | CYP2F1, PPOX, CYP11B2 | LMNA 2820/4885MYC 3659/4885MALT1 2465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.